INNOVENT ANNOUNCES POSITIVE CHMP OPINION, RECOMMENDING ZYBRIVO® (SINTILIMAB) FOR FIRST-LINE TREATMENT OF NON-SQUAMOUS NON-SMALL CELL LUNG CANCER

Reuters · 2d ago

Please log in to view news